MET and colorectal carcinoma: We have previously demonstrated that enhanced expression of the selective EGFR ligand transforming growth factor α (TGFα) in cetuximab-resistant CRC cells is responsible for EGFR-MET interaction and subsequent MET phosphorylation and activation [12].